Related Experiment Videos
[Left ventricular hypertrophy and arrhythmia. An aspect of hypertensive cardiomyopathy]
J Clémenty1, M N Dulhoste, P Coste
1Hôpital Cardiologique, université de Bordeaux, Pessac.
Insights
Left ventricular hypertrophy (LVH) is linked to sudden cardiac death and arrhythmias in hypertensive patients. The exact cause of these arrhythmias in LVH remains unclear, though electrolyte balance is key.
Area of Science:
- Cardiology
- Electrophysiology
- Hypertension Research
Context:
- Epidemiological studies show a strong link between left ventricular hypertrophy (LVH) and sudden cardiac death.
- Hypertensive individuals with LVH exhibit a higher prevalence of both ventricular and atrial arrhythmias.
- The precise relationship between LVH as a marker or cause and observed arrhythmias is not fully understood.
Purpose:
- To explore the association between left ventricular hypertrophy (LVH) and cardiac arrhythmias.
- To identify potential arrhythmogenic substrates and markers of severity in patients with LVH.
- To review the multifactorial mechanisms contributing to arrhythmias in the context of LVH.
Summary:
- LVH is independently associated with sudden cardiac death and increased prevalence of arrhythmias in hypertensive patients.
- Arrhythmias in LVH patients are multifactorial, involving ischemia, fibrosis, sympathetic tone, and electrolyte imbalances.
- ECG parameters (LVH with overload), echocardiographic mass (>+20%), and septal thickness (>12 mm) are sensitive markers of LVH severity.
Impact:
- Understanding the link between LVH and arrhythmias can improve risk stratification for sudden cardiac death.
- Identifying arrhythmogenic substrates may lead to targeted therapies for arrhythmias in LVH patients.
- Maintaining electrolyte balance is highlighted as a crucial, unquestioned therapeutic intervention.
Abstract:
Epidemiological data has established a relationship between left ventricular hypertrophy (LVH) and sudden cardiac death. This relationship is independent. The search for ventricular and atrial arrhythmias in hypertensives confirms a greater prevalence of these arrhythmias in patients with LVH. The mechanism of these arrhythmias is multifactorial: ischemia, subendocardial fibrosis, increased sympathetic tone, electrolyte disturbances, age, and hemodynamic changes may be arrhythmogenic substrates both at the ventricular and auricular levels. The relationship between LVH (marker or cause) and the detected arrhythmias remain obscure. The most sensitive markers of severity seem to be the ECG parameters (LVH with overload), echocardiographic mass (greater than + 20%) and septal thickness (greater than 12 mm). The evolution of arrhythmias with regression of LVH is unknown. Respect of electrolyte equilibrium would seem to be the only unquestioned therapeutic intervention.